US 5,292,752 AGranted

Antithrombotic compounds

AssigneeMerrell Dow Pharmaceuticals Inc.

InventorsAlbert A. Carr, Richard C. Dage, John E. Koerner, Tung Li, Francis P. Miller, Thaddeus R. Nieduzak

Life of this patent

Estimating the term…

Abstract

The present invention is directed to a new class of piperidinyl medicinal agents which are useful as antithrombotic agents and as serotonin 5HT.sub.2 antagonists.

Claims15

Dependent claims

A compound of the formula:

##STR5## in which X is represented by CO or SO.sub.2 and the pharmaceutically acceptable acid addition salts thereof.

Dependencies are inferred from the claim text.

Facts

Application: 07/847,971Filed 5 Mar 1992 · continuation in part
Priority: 21 Dec 1989
Granted: 8 Mar 1994
Term ends: Not estimatedThe source records don’t support an estimate.

Classification2 codes

C07D 211/32
With hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon…
C07D
Heterocyclic compounds

Family

Serial454,497Parent of this continuation-in-part · filed 21 Dec 1989
Serial604,651Parent of this continuation-in-part · filed 1 Nov 1990
Serial673,888Parent of this continuation-in-part · filed 22 Mar 1991
US 5,292,752 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…